IceCure Medical Ltd (ICCM)
ICCM Stock Price Chart
Explore IceCure Medical Ltd interactive price chart. Choose custom timeframes to analyze ICCM price movements and trends.
ICCM Company Profile
Discover essential business fundamentals and corporate details for IceCure Medical Ltd (ICCM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
26 Aug 2021
Employees
64.00
Website
https://www.icecure-medical.comCEO
Eyal Shamir
Description
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
ICCM Financial Timeline
Browse a chronological timeline of IceCure Medical Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 25 Nov 2025
EPS estimate is -$0.06.
Earnings released on 13 Aug 2025
EPS came in at $0.06 surpassing the estimated -$0.06 by +200.00%, while revenue for the quarter reached $156.85K , missing expectations by -75.45%.
Earnings released on 28 May 2025
EPS came in at -$0.06 surpassing the estimated -$0.08 by +25.00%, while revenue for the quarter reached $193.79K , missing expectations by -78.48%.
Earnings released on 27 Mar 2025
EPS came in at -$0.08 falling short of the estimated -$0.07 by -14.29%, while revenue for the quarter reached $240.14K , missing expectations by -77.50%.
Earnings released on 26 Nov 2024
EPS came in at -$0.08 falling short of the estimated -$0.07 by -14.29%, while revenue for the quarter reached $174.21K , missing expectations by -75.41%.
Earnings released on 20 Aug 2024
EPS came in at -$0.06 surpassing the estimated -$0.07 by +14.29%, while revenue for the quarter reached $268.45K , missing expectations by -70.99%.
Earnings released on 28 May 2024
EPS came in at -$0.08 matching the estimated -$0.08, while revenue for the quarter reached $199.56K , missing expectations by -80.38%.
Earnings released on 3 Apr 2024
EPS came in at -$0.07 matching the estimated -$0.07, while revenue for the quarter reached $365.92K , missing expectations by -68.64%.
Earnings released on 15 Nov 2023
EPS came in at -$0.09 matching the estimated -$0.09, while revenue for the quarter reached $85.15K , missing expectations by -91.67%.
Earnings released on 14 Aug 2023
EPS came in at -$0.09 matching the estimated -$0.09, while revenue for the quarter reached $253.67K , missing expectations by -72.85%.
Earnings released on 22 May 2023
EPS came in at -$0.08 surpassing the estimated -$0.09 by +11.11%, while revenue for the quarter reached $197.87K , missing expectations by -79.17%.
Earnings released on 29 Mar 2023
EPS came in at -$0.11 falling short of the estimated -$0.09 by -22.22%, while revenue for the quarter reached $272.26K .
Earnings released on 5 Dec 2022
EPS came in at -$0.11 matching the estimated -$0.11, while revenue for the quarter reached $178.67K .
Earnings released on 15 Aug 2022
EPS came in at -$0.12 matching the estimated -$0.12, while revenue for the quarter reached $219.08K .
Earnings released on 18 May 2022
EPS came in at -$0.12 , while revenue for the quarter reached $233.44K .
Earnings released on 1 Apr 2022
EPS came in at -$0.10 , while revenue for the quarter reached $444.77K .
Earnings released on 23 Nov 2021
EPS came in at -$0.03 , while revenue for the quarter reached $211.17K .
Earnings released on 23 Sept 2021
EPS came in at -$0.03 , while revenue for the quarter reached $194.96K .
Stock split effective on 9 Aug 2021
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Apr 2021
EPS came in at -$0.01 , while revenue for the quarter reached $427.92K .
Earnings released on 31 Mar 2021
EPS came in at -$0.02 , while revenue for the quarter reached $430.71K .
Earnings released on 30 Sept 2020
EPS came in at -$0.03 , while revenue for the quarter reached $185.00K .
ICCM Stock Performance
Access detailed ICCM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.